Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Shareholder vote
confidence 95%
filed 2026-07-08
The 6-K discloses the results of an Annual General Meeting held on July 7, 2026, with voting outcomes on ten proposals including adoption of financial statements, director re-elections (Thomas Peter Power and Eva Maria Mantziou), auditor re-appointment, and authorization for share issuances and buybacks. This is a classic shareholder_vote_results disclosure. The approval of significant governance and capital authorization matters (share issuances, buyback mandate, share consolidation authority) makes this material to investors assessing the company's governance and capital structure.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-07-08
EX-99.1
The exhibit announces completion of a $1.0 million share repurchase program in which Vantage repurchased 1,076,610 Class A ordinary shares at an aggregate net cost of $997,897.72 from November 6, 2025 to June 30, 2026. Share repurchases are a form of return of capital to shareholders and fall within the dividend_distribution category, which explicitly includes "share-repurchase programs." The completion of a previously authorized program is a discrete capital allocation event material to investors assessing shareholder value.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-08
Fusemachines disclosed that on July 7, 2026, it received notification from Nasdaq that it has "regained compliance with Nasdaq Listing Rule 5450(b)(1)(C), which requires the Company to maintain a minimum market value of publicly held shares of $15,000,000." This disclosure directly addresses a delisting risk—the company had previously fallen below the minimum market value threshold and faced potential delisting, but has now remedied that deficiency. The resolution of a listing compliance matter is material to investors assessing the registrant's continued trading status.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-08
Item 1.01
The filing discloses entry into and consummation of an asset purchase agreement on July 1, 2026, whereby the Company's subsidiary Live Blue acquired substantially all assets of Sunrise Paddleboards (a paddleboarding and kayaking business) in exchange for 42 million shares of common stock. This is a material acquisition transaction under Item 1.01, representing a significant business combination that would materially affect investor assessment of the registrant's operations and capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-08
The filing discloses the appointment of Brent Morrison as an independent trustee of Power REIT, effective immediately on July 6, 2026. The Board explicitly states it appointed Morrison to serve until the next annual meeting and highlights his significant executive leadership experience at a publicly traded healthcare company, indicating the Board views his appointment as materially valuable to the Trust's governance and strategic objectives.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-08
The filing discloses the Board of Directors' approval on July 5, 2026, of Mr. John E. Driscoll's appointment as Co-Chief Operating Officer of Blue Chip Capital Group, Inc. The disclosure includes detailed biographical information, professional credentials (CFE, CIA), and extensive experience in corporate finance, accounting, and risk management. This is a clear executive appointment to a senior officer role, making it material to investors' assessment of the company's leadership and operational capacity.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-07-08
Digital Brands Group announced retention of outside counsel (Christian Attar law firm) and engagement of Shareholder Intelligence Services to investigate and pursue legal action against parties allegedly engaged in naked short selling, market manipulation, spoofing, and other securities law violations. The company explicitly states its intent to "aggressively pursue through counsel any party responsible for losses" and to provide evidence to the DOJ, SEC, and Ontario Securities Commission. This constitutes a material litigation and regulatory investigation disclosure under Item 8.01.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-08
Newton Golf Company entered into a Loan and Security Agreement with Brynnwood, LLLP on July 1, 2026, establishing a senior secured revolving credit facility of up to $5,000,000 with a two-year maturity. This is a creation of a new direct financial obligation disclosed under Item 1.01 and Item 2.03, representing material debt financing that would affect a reasonable investor's assessment of the company's capital structure and financial obligations.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 85%
filed 2026-07-08
The 6-K discloses results of Einride AB's Annual General Meeting held on June 30, 2026, where shareholders approved all matters submitted. The filing also reports the election of R. Lynn Atchison and the subsequent reorganization of board committees, including her appointment to the audit and nominations committees. This constitutes a shareholder vote result with material governance consequences.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-08
EX-99.1
This press release announces the commencement of operations on the K-29 well at the Kruh Block, a material operational milestone for an oil and gas E&P company. The disclosure describes progress on a planned drilling program, submission of environmental clearances for 30 additional wells, and the company's long-term development strategy. While this is an operational achievement rather than a discrete event type (M&A, impairment, litigation, etc.), it materially affects investor assessment of the company's execution capability and asset development trajectory.
View raw filing on EDGAR →
8-K
Restatement
confidence 98%
filed 2026-07-08
The filing discloses under Item 4.02 that the Board concluded the Company's previously issued financial statements for Q3 2024, full-year 2024, Q1 2025, and Q2 2025 "contain certain errors and misstatements that must be corrected and that the Original Financial Statements must be restated." The restatement encompasses multiple periods and includes adjustments to earnings per share, tax amounts, and common stock subject to redemption. Additionally, the Company disclosed a material weakness in internal controls over financial reporting, indicating systemic accounting deficiencies that necessitate the restatement.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-08
The filing discloses multiple governance events: departure of CEO Renger van den Heuvel effective June 30, 2026; appointment of Ana Rita Coelho as Interim CEO; reconstitution of the Board with five directors; and implementation of enhanced corporate governance framework including formal Audit Committee establishment and Charter adoption. While this involves both an exec_departure and exec_appointment, the filing centers on the broader governance restructuring and board transition rather than a single personnel action, making governance_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-08
The filing discloses the closing of a Securities Purchase Agreement with Dune Equity Holdings LLC on July 2, 2026, under which Netcapital issued a convertible promissory note for $290,000 principal (with $40,000 original issue discount) and a common stock purchase warrant for 250,000 shares. Item 1.01 and Item 2.03 explicitly document the creation of a direct financial obligation. While the filing also involves an unregistered equity issuance (Item 3.02), the primary material event is the debt issuance, as the note is the principal obligation with defined amortization, interest, and default provisions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-08
The filing discloses termination of a Business Combination Agreement with United Hydrogen Group Inc., originally entered into on June 19, 2024 and amended June 6, 2025. Item 1.02 explicitly states the agreement terminated on July 7, 2026 pursuant to Section 9.1(b) due to the outside date passing without consummation. This is a material M&A event—the termination of a proposed business combination—that would significantly affect investor assessment of the registrant's strategic direction and capital structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-08
XCF Global entered into a $1,000,000 senior secured loan with Brown Stone Capital Limited on July 1, 2026, creating a new direct financial obligation. The filing discloses material terms including a 25% original issue discount, 10% annual interest, 60-day maturity, and a 500,000-share commitment fee. While the filing also mentions an unregistered equity issuance (Item 3.02), the primary disclosed event is the debt issuance itself, which is material to investors assessing the company's capital structure and liquidity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-08
Item 2.02
Neostellar Capital Corp. issued a press release on July 8, 2026 disclosing preliminary Q2 2026 financial results, including net asset value per share of $13.25–$13.75, portfolio composition of 37 companies, investment activity of $24.7 million deployed, and realized gains.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-07-08
The filing discloses entry into a securities purchase agreement for a convertible promissory note with a principal amount of $166,500 sold for $150,000 net funding of $141,000 to Coventry Enterprises LLC. The Note is convertible into common stock at 85% of the lowest closing bid price during the ten trading days prior to conversion, with conversion restrictions tied to beneficial ownership thresholds and Nasdaq Rule 5635(d) shareholder approval requirements. This is a dilutive equity issuance structured as a convertible debt instrument, disclosed under Items 1.01, 2.03, and 3.02, representing a material capital-raising transaction with significant dilution potential to existing shareholders.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-08
Two Hands Corporation voluntarily delisted its common shares from the Canadian Securities Exchange (CSE) effective July 7, 2026. While this is a voluntary delisting (not a forced delisting due to non-compliance), it represents a material change in the registrant's listing status and trading venue. The company's shares continue trading on OTC Markets under "TWOH," but the removal from the CSE is a significant corporate action affecting investor access and liquidity. The filing explicitly states this decision was made after evaluating costs, administrative requirements, and transaction opportunities, indicating a strategic shift in capital markets presence.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-07-08
Item 1.01
GoPro entered into a securities purchase agreement on July 1, 2026, to issue $20 million in aggregate principal amount of senior secured notes at 6.50% interest maturing July 21, 2028, along with warrants to purchase 25,706,940 shares of Class B common stock to entities affiliated with founder and CEO Nicholas Woodman. The transaction creates a significant new direct financial obligation for the company.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-07-08
Item 8.01
The filing discloses that Upland Software has regained compliance with Nasdaq Listing Rule 5450(a)(1) minimum bid price requirement after previously falling below the $1.00 threshold. While the current disclosure is positive (compliance regained), it necessarily implies prior non-compliance with a continued listing rule, which is the material delisting risk event. The letter from Nasdaq dated July 2, 2026 confirms the company met the minimum bid price for 10 consecutive business days and the matter is now closed, resolving the delisting threat.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-07-08
Item 7.01
Voya Financial is furnishing preliminary estimates of alternative investment income and investment capital returns for Q2 2026 prior to the full earnings release scheduled for August 4, 2026. The disclosure provides a pre-tax loss range of $9–$19 million and annualized return metrics. While this is a financial disclosure under Item 7.01 (Regulation FD), it does not constitute a formal earnings release (which would be Item 2.02 and typically attached as an exhibit), nor does it fit other specific financial event types. The preliminary nature and materiality to investors' understanding of quarterly performance support classification as a financial event, though the lack of complete financial statements and auditor review suggests this is supplemental guidance rather than a full earnings announcement.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-08
Item 5.02
The Board ratified a new Company-wide annual incentive program (AIP) and approved specific fiscal 2026 AIP award payouts for named executive officers, including $602,784 for CEO Mark A. Smith, $345,621 for CFO Neal S. Shah, and $378,197 for COO Scott Honan. This is a compensatory arrangement disclosure under Item 5.02(e), establishing both a formal incentive plan framework and concrete awards to senior executives.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-08
EX-99.1
This press release announces Pembina's role as a partner in the Greenlight Electricity Centre, a dedicated power generation project supporting Meta's new data centre investment in Alberta. The disclosure highlights a strategic business development milestone — a "positive final investment decision" on gas-to-power infrastructure that represents "a promising new growth platform" for Pembina. While the announcement celebrates a partnership and project milestone rather than a discrete M&A transaction or operational restructuring, it discloses a material strategic initiative that would affect a reasonable investor's assessment of Pembina's growth prospects and new business lines in the energy transition space.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-07-08
The filing discloses that the Board of Directors accepted the resignation of Manuel Adorni, a Class A Regular Director of YPF S.A., effective July 8, 2026. This is a clear departure of a director from the registrant's board, reported to Argentine securities regulators (CNV, ByMA, A3 Mercados) as required by local rules. Director departures are material governance events affecting the composition of the board.
View raw filing on EDGAR →
8-K
M&A activity
confidence 90%
filed 2026-07-08
Item 1.01
Evolus entered into an exclusive License, Supply and Distribution Agreement with IBSA on July 7, 2026, granting exclusive rights to develop, commercialize, and distribute Profhilo® in the United States. The 15-year initial term agreement with renewal options expands the company's injectable portfolio into the skin-quality segment and includes minimum purchase requirements structured with a transfer-price model designed to support gross margins consistent with the company's long-term financial framework.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-08
ECARX entered into a share exchange agreement with Qualcomm Ventures LLC on July 7, 2026, whereby Qualcomm will acquire 10,329,562 Class A ordinary shares at a VWAP-determined price, with settlement via transfer of Qualcomm's equity interest in DreamSmart. This constitutes a material acquisition-related transaction involving a significant equity stake and intellectual property rights, expected to close in August 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-08
Item 7.01
Dream Finders Homes has submitted a revised all-cash acquisition proposal to Beazer Homes USA, Inc. for $32.00 per share, representing a 70% premium to Beazer's undisturbed share price. The filing discloses entry into material acquisition activity—specifically a proposed change of control transaction involving the acquisition of all outstanding shares of Beazer. This is a core M&A event that would materially affect investor assessment of both companies' strategic direction and financial position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-08
Item 5.02
The filing discloses both the departure of Jeffrey Rona as Chief Business and Financial Officer and the appointment of Charles Carter as Chief Financial Officer, effective July 6, 2026. While both events occur, the principal disclosed action centers on Carter's appointment to the CFO role with detailed compensation arrangements (base salary of $460,000, 35% bonus target, 50,000 RSU grant), making exec_appointment the most salient classification. The departure is secondary context to the succession event.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-08
EX-99.1
This is a press release announcing Q2-2026 operational and production results for Aya Gold & Silver's Zgounder Silver Mine and Boumadine pyrite reclaim operation. The document discloses record quarterly production metrics (1.68 Moz AgEq, up 61% YoY), record mining and processing rates, and detailed operational summaries with comparative period data. While styled as an operational update rather than a financial earnings release, it serves the functional equivalent by reporting material production results and operational performance for a discrete reporting period, which would affect a reasonable investor's assessment of the mining company's operational trajectory and ability to meet 2026 production targets.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-07-08
Item 8.01
Prime Medicine disclosed a final arbitration award resolving a material dispute with Beam Therapeutics over the 2019 Collaboration and License Agreement. The Tribunal ruled in Prime's favor, declaring PM647 falls within Prime's "Field" and denying Beam's claims for damages and injunctive relief. This favorable resolution of a material contractual dispute affecting the Company's development rights is a significant legal event that would affect a reasonable investor's assessment of Prime's ability to continue developing PM647 for AATD.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-08
Item 2.01
Azenta completed the sale of its B Medical Systems business to Thelema S.à r.l. for $63 million in cash on July 1, 2026, with $35 million funded via a vendor loan. The transaction involved entry into material definitive agreements (Vendor Loan Agreement, Share Pledge Agreement, and Deed of Amendment) and has been classified as a significant disposition under Item 2.01, with B Medical reclassified as a discontinued operation.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-08
Item 3.02
The filing discloses an unregistered sale of equity securities under Item 3.02, with the Company issuing 2,597,313 shares across three classes (S-PR, D-PR, and I-PR) on July 1, 2026, generating approximately $21.35 million in gross proceeds pursuant to Regulation D and a distribution reinvestment plan. This is a classic dilutive issuance of unregistered equity that would materially affect a reasonable investor's assessment of share dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-08
Item 3.02
The filing discloses unregistered sales of equity securities under Item 3.02, reporting issuance of 3,074,933 shares across three classes (Class S-PR, D-PR, and I-PR) generating approximately $40.96 million in gross proceeds during June–July 2026, pursuant to Regulation D exemption. This is a classic dilutive equity issuance that would materially affect investor assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-08
Item 5.02
Michael Keogh's appointment as Chief Financial Officer effective August 5, 2026, is the principal disclosed action. While the filing also details his compensation package (base salary of $595,000, 85% target bonus, $2M RSU grant, and severance arrangements), the core event is the appointment of a named executive officer to a C-suite position. The disclosure emphasizes his extensive background at Ford, Apple, Stanley Black & Decker, and Intel, and his role is material to investors assessing the company's leadership and financial management capabilities.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 82%
filed 2026-07-08
Item 1.01
Voyager Technologies entered into a Fourth Amendment to its Credit Agreement on July 6, 2026, increasing aggregate commitments by $50 million to $250 million and modifying covenants. This material amendment expands the Company's borrowing capacity and modifies the terms of its existing credit facility.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-08
Item 8.01
The filing discloses a declaration by the Board of Directors of a monthly dividend of $0.13 per share of common stock, payable on August 31, 2026 to stockholders of record as of July 31, 2026. This is a routine but material dividend distribution announcement typical of REITs like Ellington Financial, which are required to distribute substantially all taxable income to shareholders. The disclosure directly matches the dividend_distribution event type.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-08
Item 8.01
The filing discloses a declaration by the Board of Trustees of a monthly common dividend of $0.08 per share, payable on August 31, 2026 to shareholders of record as of July 31, 2026. This is a routine but material dividend declaration for a closed-end fund (Ellington Credit Company), which is a standard capital distribution to shareholders and would affect investor assessment of the fund's income distribution policy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 96%
filed 2026-07-08
Item 5.02
Michael Axelrod was appointed as President and Chief Executive Officer and Board member effective July 29, 2026, following a comprehensive external search. The appointment includes detailed compensation arrangements including a base salary of $1,000,000 and equity awards of $4,750,000, along with severance and change-in-control protections.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-07-08
Item 7.01
GitLab disclosed updated business information via investor relations slides covering Q1 FY27 results, new product initiatives (Flex consumption-based buying program, Duo Agent Platform, GitLab Orbit), and architectural strategy bets. While the filing emphasizes this is a Regulation FD disclosure of summary information not material to current financial performance, the substantive content—including 100% YoY first-order growth in Q2 FY27-to-date, new consumption metrics (CRR surpassing $20M), and strategic platform innovations—represents material operational and strategic updates that would affect a reasonable investor's assessment of the company's growth trajectory and product direction.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-08
Guardian Metal announced entry into a strategic partnership with the Montana Mining Association, Montana Technological University, and the Army Research Laboratory to advance a tungsten mining and recovery pilot program. The partnership involves supplying stockpiled ore from Tempiute for processing trials, with initial shipments expected by late summer 2026. This is a material operational and strategic milestone for a tungsten exploration company, validating its project portfolio and advancing its domestic supply-chain strategy, but does not constitute a discrete M&A transaction, financing event, or other specifically-named event type.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-08
Item 1.01
Onfolio Holdings entered into a binding Letter of Intent to acquire Paramount Helium LLC in a merger or business combination, whereby the Company will issue 50 million shares of convertible preferred stock and receive rights to acquire Proton Green's senior secured indebtedness. The transaction includes a name change to Paramount Helium Corporation, board restructuring, and executive leadership changes, positioning the Company in the $122 billion global industrial gas market with access to an estimated $3 billion US-based helium resource.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-08
Item 5.02
The filing discloses the appointment of Charles Weiser as Chief Financial Officer effective July 1, 2026, along with a detailed employment agreement specifying base salary ($225,000), performance bonus (up to 75% of base), signing bonus ($25,000), and equity grants (150,000 options and 125,000 RSUs). While the disclosure includes compensatory arrangements, the principal disclosed action is the appointment of a named executive to a C-suite officer role, making exec_appointment the most salient classification. The appointment of a CFO is material to investors assessing the registrant's financial leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-08
Item 5.02
Michael McDonnell was appointed to Moderna's Board of Directors effective July 8, 2026, and simultaneously appointed to the Audit Committee. McDonnell brings extensive CFO experience from major life sciences companies including Biogen and IQVIA.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-08
Item 1.01
Nocera entered into a binding letter of intent on July 6, 2026, to acquire up to 9.99% of INERGX Energy Optimisation Ltd, a strategic equity investment in an energy storage and power platform company, with consideration consisting of cash and/or Company common stock. This transaction is positioned as a significant milestone in Nocera's transformation strategy into a diversified technology holding company.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-08
Item 5.03
The Board approved and implemented a 1-for-30 reverse stock split, effective as of the filing date, to satisfy the minimum bid price requirement for continued listing on The Nasdaq Capital Market. This is a proactive capital structure amendment to maintain compliance with Nasdaq listing standards.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 94%
filed 2026-07-08
Item 1.01
AEP Texas Inc. entered into a DOE Loan Guarantee Agreement and FFB Note Purchase Agreement on July 7, 2026, creating a new direct financial obligation of up to $3.26 billion in guaranteed debt financing through the Federal Financing Bank. The multi-draw term loan facility matures on April 15, 2056, bears interest at U.S. Treasury rate plus 0.375%, and the Company paid $8.43 million in fees to DOE at closing.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-08
Item 3.02
Sadot Group Inc. issued 90,000 unregistered shares of Common Stock (approximately 9% of outstanding common stock) to two creditors—Cedar and Agile—in settlement of approximately $3.36 million in outstanding debt, utilizing Section 3(a)(9) and Section 4(a)(2) exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-08
Item 1.01
Tarsus Pharmaceuticals completed its acquisition of iRenix Medical, Inc., a clinical-stage ophthalmic biopharmaceutical company, for approximately $75 million in upfront consideration ($37.5 million cash and 607,093 shares of stock) plus up to $490 million in milestone payments and revenue sharing. The transaction includes the acquisition of IRX-101, a late-stage asset that expands Tarsus's pipeline in eye care.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-08
The filing discloses the scheduling of an Extraordinary General Meeting for July 29, 2026, to approve a previously announced business combination between BCAR (a SPAC) and Exascale Labs Inc. The merger agreement was entered into on January 11, 2026, and the combined company is expected to operate as Exascale Labs Holdings Inc. trading under ticker "XLAB." This is a material acquisition/change of control event requiring shareholder approval, consistent with Item 8.01 disclosure of M&A activity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-08
The 8-K discloses financial results for the quarter and six months ended April 30, 2026, with specific revenue figures ($2,581,000 for Q2 vs. $1,149,000 prior year; 124.6% growth) and gross margin data (80.0% maintained). Item 2.02 explicitly references "Results of Operations and Financial Condition," and the attached press release (Exhibit 99.1) announces these results as a formal earnings disclosure. This is a classic earnings release disclosure under Item 2.02.
View raw filing on EDGAR →